Robert G. Franz

551 total citations
14 papers, 365 citations indexed

About

Robert G. Franz is a scholar working on Organic Chemistry, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Robert G. Franz has authored 14 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 5 papers in Molecular Biology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robert G. Franz's work include Receptor Mechanisms and Signaling (3 papers), Synthesis and Reactivity of Sulfur-Containing Compounds (2 papers) and Synthesis and Reactions of Organic Compounds (2 papers). Robert G. Franz is often cited by papers focused on Receptor Mechanisms and Signaling (3 papers), Synthesis and Reactivity of Sulfur-Containing Compounds (2 papers) and Synthesis and Reactions of Organic Compounds (2 papers). Robert G. Franz collaborates with scholars based in United States, Chile and United Kingdom. Robert G. Franz's co-authors include Joseph Weinstock, Dimitri E. Gaitanopoulos, James M. Samanen, Gerald R. Girard, Richard M. Keenan, Joseph A. Finkelstein, John G. Gleason, Judith C. Hempel, David T. Hill and Stephen T. Ross and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Cell Biochemistry and Function.

In The Last Decade

Robert G. Franz

13 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert G. Franz United States 9 175 151 72 42 30 14 365
Anthony K. L. Fung United States 13 273 1.6× 201 1.3× 88 1.2× 33 0.8× 35 1.2× 20 456
A Tajana Italy 10 76 0.4× 169 1.1× 45 0.6× 27 0.6× 14 0.5× 41 382
Javed Iqbal India 12 102 0.6× 165 1.1× 22 0.3× 23 0.5× 22 0.7× 48 361
Takashi Kariya Japan 10 203 1.2× 91 0.6× 133 1.8× 20 0.5× 21 0.7× 18 449
Magdy N. Iskander Australia 11 169 1.0× 141 0.9× 12 0.2× 17 0.4× 35 1.2× 32 395
Yoshikazu Oka Japan 13 182 1.0× 137 0.9× 18 0.3× 14 0.3× 13 0.4× 48 421
Daniel G. Marquess United States 17 460 2.6× 490 3.2× 34 0.5× 86 2.0× 10 0.3× 28 922
Wei-guo Su United States 12 198 1.1× 221 1.5× 97 1.3× 13 0.3× 6 0.2× 21 496
Robert G. Bianchi United States 13 95 0.5× 150 1.0× 18 0.3× 61 1.5× 8 0.3× 42 537
Kazuhiro Kosakai Japan 11 110 0.6× 239 1.6× 48 0.7× 17 0.4× 96 3.2× 18 404

Countries citing papers authored by Robert G. Franz

Since Specialization
Citations

This map shows the geographic impact of Robert G. Franz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert G. Franz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert G. Franz more than expected).

Fields of papers citing papers by Robert G. Franz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert G. Franz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert G. Franz. The network helps show where Robert G. Franz may publish in the future.

Co-authorship network of co-authors of Robert G. Franz

This figure shows the co-authorship network connecting the top 25 collaborators of Robert G. Franz. A scholar is included among the top collaborators of Robert G. Franz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert G. Franz. Robert G. Franz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Franz, Robert G.. (2001). Comparisons of pKa and log P values of some carboxylic and phosphonic acids: Synthesis and measurement. PubMed. 3(2). 1–13. 73 indexed citations
2.
Weinstock, Joseph, David T. Hill, Richard M. Keenan, et al.. (1994). A potent long-acting imidazole-5-acrylic acid angiotensin II AT-1 receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 4(1). 23–28. 7 indexed citations
3.
Franz, Robert G., Joseph Weinstock, Raul R. Calvo, James M. Samanen, & Nambi Aiyar. (1994). SYNTHESIS OF A S-4-CARBOXYPHENYLALANINE DERIVATIVE FOR USE IN PEPTIDE SYNTHESIS. Organic Preparations and Procedures International. 26(5). 533–538. 2 indexed citations
4.
Keenan, Richard M., Joseph Weinstock, Joseph A. Finkelstein, et al.. (1993). Potent nonpeptide angiotensin II receptor antagonists. 2. 1-(Carboxybenzyl)imidazole-5-acrylic acids. Journal of Medicinal Chemistry. 36(13). 1880–1892. 42 indexed citations
5.
Keenan, Richard M., Joseph Weinstock, Joseph A. Finkelstein, et al.. (1992). Imidazole-5-acrylic acids: potent nonpeptide angiotensin II receptor antagonists designed using a novel peptide pharmacophore model. Journal of Medicinal Chemistry. 35(21). 3858–3872. 34 indexed citations
6.
Weinstock, Joseph, Richard M. Keenan, James M. Samanen, et al.. (1991). 1-(Carboxybenzyl)imidazole-5-acrylic acids: potent and selective angiotensin II receptor antagonists. Journal of Medicinal Chemistry. 34(4). 1514–1517. 98 indexed citations
7.
Franz, Robert G. & Joseph Weinstock. (1988). A Convenient Method for the Large Scale Preparation of (E)-4-Oxo-2-Butenoic Acid Ethyl Ester. Synthetic Communications. 18(16-17). 1913–1917. 1 indexed citations
8.
Weinstock, Joseph, Dimitri E. Gaitanopoulos, Orum D. Stringer, et al.. (1987). Synthesis and evaluation of non-catechol D-1 and D-2 dopamine receptor agonists: benzimidazol-2-one, benzoxazol-2-one, and the highly potent: benzothiazol-2-one 7-ethylamines. Journal of Medicinal Chemistry. 30(7). 1166–1176. 30 indexed citations
9.
Ross, Stephen T., Robert G. Franz, Gregory Gallagher, et al.. (1987). Dopamine agonists related to 3-allyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol, 6-position modifications. Journal of Medicinal Chemistry. 30(1). 35–40. 5 indexed citations
10.
DeMarinis, Robert M., Gregory Gallagher, Ralph F. Hall, et al.. (1986). ChemInform Abstract: Syntheses and in vitro Evaluation of 4‐(2‐Aminoethyl)‐2(3H)‐indolones and Related Compounds as Peripheral Prejunctional Dopamine Receptor Agonists.. Chemischer Informationsdienst. 17(43). 1 indexed citations
11.
Ross, Stephen T., Robert G. Franz, James W. Wilson, et al.. (1986). Dopamine receptor agonists: 3-allyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol and a series of related 3-benzazepines. Journal of Medicinal Chemistry. 29(5). 733–740. 8 indexed citations
12.
DeMarinis, Robert M., Ralph F. Hall, Robert G. Franz, et al.. (1986). Syntheses and in vitro evaluation of 4-(2-aminoethyl)-2(3H)-indolones and related compounds as peripheral prejunctional dopamine receptor agonists. Journal of Medicinal Chemistry. 29(6). 939–947. 33 indexed citations
13.
Lissi, E. A., et al.. (1986). Effects of antioxidants and haemoglobin status on the t‐butyl hydroperoxide‐induced oxygen uptake by red blood cells. Cell Biochemistry and Function. 4(1). 61–68. 20 indexed citations
14.
Ross, Stephen T., Robert G. Franz, James W. Wilson, R Hahn, & Henry M. Sarau. (1986). Synthesis, renal vasodilator and dopamine‐sensitive adenylate cyclase activities ofO‐Methyl derivatives of 6‐chloro‐2,3,4,5‐tetr ahydro‐1‐(4‐hydroxyphenyl)‐1H‐3‐benzazepin‐7,8‐diol (SK&F 82526). Journal of Heterocyclic Chemistry. 23(6). 1805–1814. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026